IFN-γ induced persistent Chlamydia pneumoniae infection in HL and Mono Mac 6 cells: Characterization by real-time quantitative PCR and culture

Microbial Pathogenesis

Volumn 36, Issue 1, 2004, Pages 41-50

  Mannonen, Laura ^a,b   Kamping, Eveline ^a,b,c   Penttilä, Tuula ^a,b   Puolakkainen, Mirja ^a,b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Chlamydia pneumoniae; Persistent infection; Quantitative PCR

Indexed keywords

BACTERIAL DNA; GAMMA INTERFERON;

ARTICLE; BACTERIAL GENOME; BACTERIAL GROWTH; BACTERIAL INFECTION; CELL CULTURE; CELL DIFFERENTIATION; CELL GROWTH; CELL LINE; CHLAMYDOPHILA PNEUMONIAE; DNA REPLICATION; ELEMENTARY PARTICLE; EPITHELIUM CELL; HUMAN; HUMAN CELL; INOCULATION; MACROPHAGE; MONOCYTE; NONHUMAN; PERSISTENT INFECTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE GENETICS;

CHLAMYDIA; CHLAMYDOPHILA PNEUMONIAE;

EID: 0344393671     PISSN: 08824010     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.micpath.2003.09.001     Document Type: Article

References (38)

1. Kuo C.C., Jackson L.A., Campbell L.A., Grayston J.T. Chlamydia pneumoniae (TWAR). Clin Microbiol Rev. 8:1995;451-461.
2. Hammerschlag M.R., Chirgwin K., Roblin P.M., Gelling M., Dumornay W., Mandel L., Smith P., Schachter J. Persistent infection with Chlamydia pneumoniae following acute respiratory illness. Clin Infect Dis. 14:1992;178-182.
3. Saikku P., Leinonen M., Mattila K., Ekman M.R., Nieminen M.S., Mäkelä P.H., Huttunen J.K., Valtonen V. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet. ii:1988;983-986.
4. Kalayoglu M.V., Byrne G.I. A Chlamydia pneumoniae component that induces macrophage foam cell formation is chlamydial lipopolysaccharide. Infect Immun. 66:1998;5067-5072.
5. Moazed T.C., Campbell L.A., Rosenfeld M.E., Grayston J.T., Kuo C.C. Chlamydia pneumoniae infection accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice. J Infect Dis. 180:1999;238-241.
6. Liu L., Hu H., Ji H., Murdin A.D., Pierce G.N., Zhong G. Chlamydia pneumoniae infection significantly exacerbates aortic atherosclerosis in an LDLR-/- mouse model within six months. Mol Cell Biochem. 215:2000;123-128.
7. Beatty W.L., Byrne G.I., Morrison R.P. Morphologic and antigenic characterization of interferon gamma-mediated persistent Chlamydia trachomatis infection in vitro. Proc Natl Acad Sci USA. 90:1993;3998-4002.
8. Coles A.M., Reynolds D.J., Harper A., Devitt A., Pearce J.H. Low-nutrient induction of abnormal chlamydial development: a novel component of chlamydial pathogenesis. FEMS Microbiol Lett. 106:1993;193-200.
9. Clark R.B., Schatzki P.F., Dalton H.P. Ultrastructural analysis of the effects of erythromycin on the morphology and developmental cycle of Chlamydia trachomatis HAR-13. Arch Microbiol. 133:1982;278-282.
10. Moulder J.W., Levy N.J., Schulman L.P. Persistent infection of mouse fibroblasts (L cells) with Chlamydia psittaci: evidence for a cryptic Chlamydial form. Infect Immun. 30:1980;874-883.
11. Kutlin A., Roblin P.M., Hammerschlag M.R. In vitro activities of azithromycin and ofloxacin in a continuous-infection model. Antimicrob Agents Chemother. 43:1999;2268-2272.
12. Wolf K., Fischer E., Hackstadt T. Ultrastructural analysis of developmental events in Chlamydia pneumoniae-infected cells. Infect Immun. 68:2000;2379-2385.
13. Fan T., Hang L., Hu H., Shi L., McClarty G.A., Nance D.M., Greenberg A.H., Zhong G. Inhibition of apoptosis in chlamydia-infected cells: blockade of mitochondrial cytochrome c release and caspase activation. J Exp Med. 187:1998;487-496.
14. Ojcius D.M., Souque P., Perfettini J.L., Dautry-Varsat A. Apoptosis of epithelial cells and macrophages due to infection with the obligate intracellular pathogen Chlamydia psittaci. J Immunol. 161:1998;4220-4226.
15. Zhong G., Fan P., Ji H., Dong F., Huang Y. Identification of a chlamydial protease-like activity factor responsible for the degradation of host transcription factors. J Exp Med. 193:2001;935-942.
16. Kuo C.C., Grayston J.T. A sensitive cell line, HL cells, for isolation and propagation of Chlamydia pneumoniae strain TWAR. J Infect Dis. 162:1990;755-758.
17. Mathews S., George C., Flegg C., Stenzel D., Timms P. Differential expression of ompA, ompB, pyk, nlpD and Cpn0585 genes between normal and interferon-gamma treated cultures of Chlamydia pneumoniae. Microb Pathog. 30:2001;337-345.
18. Pantoja L.G., Miller R.D., Ramirez J.A., Molestina R.E., Summersgill J.T. Characterization of Chlamydia pneumoniae persistence in HEp-2 cells treated with gamma interferon. Infect Immun. 69:2001;7927-7932.
19. Koehler L., Nettelnbreker E., Hudson A.P., Ott N., Gerard H.C., Branigan P.J., Schumacher H.R., Drommer W., Zeidler H. Ultrastructural and molecular analyses of the persistence of Chlamydia trachomatis (serovar K) in human monocytes. Microb Pathog. 22:1997;133-142.
20. Airenne S., Surcel H.M., Alakärppä H., Laitinen K., Paavonen J., Saikku P., Laurila A. Chlamydia pneumoniae infection in human monocytes. Infect Immun. 67:1999;1445-1449.
21. Mathews S.A., Volp K.M., Timms P. Development of a quantitative gene expression assay for Chlamydia trachomatis identified temporal expression of sigma factors. FEBS Lett. 458:1999;354-358.
22. Beatty W.L., Morrison R.P., Byrne G.I. Persistent chlamydiae: from cell culture to a paradigm for chlamydial pathogenesis. Microbiol Rev. 58:1994;686-699.
23. Molestina R.E., Dean D., Miller R.D., Ramirez J.A., Summersgill J.T. Characterization of a strain of Chlamydia pneumoniae isolated from a coronary atheroma by analysis of the omp1 gene and biological activity in human endothelial cells. Infect Immun. 66:1998;1370-1376.
24. Kuo C., Campbell L.A. Detection of Chlamydia pneumoniae in arterial tissues. J Infect Dis. 181:2000;432-436.
25. Campbell L.A., Kuo C.C. Chlamydia pneumoniae pathogenesis. J Med Microbiol. 51:2002;623-625.
26. Huang J., DeGraves F.J., Gao D., Feng P., Schlapp T., Kaltenboeck B. Quantitative detection of Chlamydia spp. by fluorescent PCR in the LightCycler. BioTechniques. 30:2001;150-175.
27. Mygind T., Birkelund S., Falk E., Christiansen G. Evaluation of real-time quantitative PCR for identification and quantification of Chlamydia pneumoniae by comparison with immunohistochemistry. J Microbiol Meth. 46:2001;241-251.
28. Berger M., Schroder B., Daeschlein G., Schneider W., Busjahn A., Buchwalow I., Luft F.C., Haller H. Chlamydia pneumoniae DNA in non-coronary atherosclerotic plaques and circulating leukocytes. J Lab Clin Med. 136:2000;194-200.
29. Beatty W.L., Morrison R.P., Byrne G.I. Reactivation of persistent Chlamydia trachomatis infection in cell culture. Infect Immun. 63:1994;199-205.
30. Pantoja L.G., Miller R.D., Ramirez J.A., Molestina R.E., Summersgill J.T. Inhibition of Chlamydia pneumoniae replication in human aortic smooth muscle cells by gamma interferon-induced indoleamine 2, 3-dioxygenase activity. Infect Immun. 68:2000;6478-6481.
31. Summersgill J.T., Sahney N.N., Gaydos C.A., Quinn T.C., Ramirez J.A. Inhibition of Chlamydia pneumoniae growth in HEp-2 Cells Pretreated with gamma interferon and tumor necrosis factor alpha. Infect Immun. 63:1995;2801-2803.
32. Mehta S.J., Miller R.D., Ramirez J.A., Summersgill J.T. Inhibition of Chlamydia pneumoniae replication in HEp-2 cells by interferon-γ: role of tryptophan catabolism. J Infect Dis. 177:1998;1326-1331.
33. Byrne G.I., Ouellette S.P., Wang Z., Rao J.P., Lu L., Beatty W.L., Hudson A.P. Chlamydia pneumoniae expresses genes required for DNA replication but not cytokinesis during persistent infection of HEp-2 cells. Infect Immun. 69:2001;5423-5429.
34. Cles L.D., Stamm W.E. Use of HL cells for improved isolation and passage of Chlamydia pneumoniae. J Clin Microbiol. 28:1990;938-940.
35. Kuo C.C., Grayston J.T. Factors affecting viability and growth in HeLa 229 cells of Chlamydia sp. strain TWAR. J Clin Microbiol. 26:1988;812-815.
36. Sabet S.F., Simmons J., Caldwell H.D. Enhancement of Chlamydia trachomatis infectious progeny by cultivation of HeLa 229 cells treated with DEAE-dextran and cycloheximide. J Clin Microbiol. 20:1984;217-222.
37. Godzik K.L., O'Brien E.R., Wang S.K., Kuo C.C. In vitro susceptibility of human vascular wall cells to infection with Chlamydia pneumoniae. J Clin Microbiol. 33:1995;2411-2414.
38. Ekman M.R., Grayston J.T., Visakorpi R., Kleemda M., Kuo C.C., Saikku P. An epidemic of infections due to Chlamydia pneumoniae in military conscripts. Clin Infect Dis. 17:1993;420-425.